Safety and pharmacokinetics of GB1211, an oral galectin-3 inhibitor: a single- and multiple-dose first-in-human study in healthy participants.
Vassilios AslanisRobert J SlackAlison C MacKinnonCatherine McClintonSusan TantawiLise GravelleUlf J NilssonHakon LefflerAshley BrooksSanjeev K KhindriRichard P MarshallAnders PedersenHans SchambyeFredrik ZetterbergPublished in: Cancer chemotherapy and pharmacology (2023)
The study was registered with ClinicalTrials.gov (identifier: NCT03809052).
Keyphrases